We are live on ! Find out more
PIA

Piedmont Investment Advisors Portfolio holdings

AUM $2.53B
1-Year Est. Return 0.83%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+0.83%
3 Year Est. Return
+35.37%
5 Year Est. Return
+69.82%
10 Year Est. Return
AUM
$2.89B
AUM Growth
+$305M
Cap. Flow
+$65.4M
Cap. Flow %
2.26%
Top 10 Hldgs %
26.78%
Holding
942
New
45
Increased
483
Reduced
384
Closed
30

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$17M
2
PFE icon
Pfizer
PFE
+$11.6M
3
LIN icon
Linde
LIN
+$9.28M
4
NKE icon
Nike
NKE
+$8.56M
5
PRU icon
Prudential Financial
PRU
+$7.44M

Sector Composition

Rank Sector Weight
1 Technology 25.58%
2 Healthcare 14.02%
3 Financials 13.08%
4 Communication Services 10.42%
5 Consumer Discretionary 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKAM icon
301
Akamai
AKAM
$16.9B
$1.2M 0.04%
13,843
+423
+3% +$37K
AGN
302
DELISTED
Allergan plc
AGN
$1.18M 0.04%
6,187
+1,072
+21% +$193K
MS icon
303
Morgan Stanley
MS
$338B
$1.18M 0.04%
23,124
+3,583
+18% +$170K
NVR icon
304
NVR
NVR
$16.8B
$1.18M 0.04%
310
+18
+6% +$66.6K
CTXS
305
DELISTED
Citrix Systems Inc
CTXS
$1.18M 0.04%
10,600
+442
+4% +$47.6K
PTC icon
306
PTC
PTC
$16.4B
$1.17M 0.04%
15,624
-1,351
-8% -$96.1K
LAMR icon
307
Lamar Advertising Co
LAMR
$15.7B
$1.14M 0.04%
12,810
-1,158
-8% -$96.9K
MASI
308
DELISTED
Masimo
MASI
$1.14M 0.04%
7,207
-621
-8% -$93.4K
BMRN icon
309
BioMarin Pharmaceuticals
BMRN
$13.3B
$1.14M 0.04%
13,465
+103
+0.8% +$7.78K
MOH icon
310
Molina Healthcare
MOH
$10.4B
$1.14M 0.04%
8,384
-791
-9% -$99.6K
MU icon
311
Micron Technology
MU
$972B
$1.12M 0.04%
20,815
-50,670
-71% -$2.42M
ANET icon
312
Arista Networks
ANET
$242B
$1.11M 0.04%
87,632
+3,824
+5% +$50.3K
BURL icon
313
Burlington
BURL
$23.4B
$1.11M 0.04%
4,880
+47
+1% +$9.82K
CRL icon
314
Charles River Laboratories
CRL
$13.2B
$1.11M 0.04%
7,281
-623
-8% -$86.3K
OMC icon
315
Omnicom Group
OMC
$23.2B
$1.11M 0.04%
13,717
+807
+6% +$63.2K
ROP icon
316
Roper Technologies
ROP
$39.9B
$1.11M 0.04%
3,128
+341
+12% +$118K
MPWR icon
317
Monolithic Power Systems
MPWR
$67.9B
$1.1M 0.04%
6,167
-477
-7% -$76.2K
HOLX
318
DELISTED
Hologic
HOLX
$1.09M 0.04%
20,982
+890
+4% +$44.3K
DCI icon
319
Donaldson
DCI
$11.2B
$1.09M 0.04%
18,991
-1,796
-9% -$97.7K
WYNN icon
320
Wynn Resorts
WYNN
$10.6B
$1.09M 0.04%
7,857
+413
+6% +$50.2K
TRV icon
321
Travelers Companies
TRV
$78.3B
$1.09M 0.04%
7,961
+759
+11% +$103K
TEAM icon
322
Atlassian
TEAM
$38.5B
$1.06M 0.04%
8,780
+1,020
+13% +$124K
EXR icon
323
Extra Space Storage
EXR
$31B
$1.05M 0.04%
9,978
+617
+7% +$67.3K
YUMC icon
324
Yum China
YUMC
$16.5B
$1.05M 0.04%
21,959
+99
+0.5% +$4.4K
SLB icon
325
SLB Ltd
SLB
$78.9B
$1.05M 0.04%
26,158
+4,636
+22% +$166K

Similar funds

Piedmont Investment Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Piedmont Investment Advisors held 942 positions worth $2.89B, up 12% from $2.58B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Piedmont Investment Advisors's Q4 2019 filing shows 45 new, 483 increased, 384 reduced and 30 closed positions. Its largest new stake was Hormel Foods: 137,108 shares worth $6.18M. The largest sale was Accenture, an estimated $14.1M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Piedmont Investment Advisors's largest Q4 2019 buy was Hormel Foods: 137,108 shares worth $6.18M.
  • Piedmont Investment Advisors added most to PepsiCo in Q4 2019, an estimated $17M increase.
  • Piedmont Investment Advisors's biggest Q4 2019 reduction was Accenture, cutting an estimated $14.1M.
  • Piedmont Investment Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $12M.
  • Piedmont Investment Advisors's ten largest holdings make up 27% of its $2.89B portfolio in Q4 2019.
  • Piedmont Investment Advisors opened 45 new positions and closed 30 in Q4 2019.
  • Piedmont Investment Advisors's portfolio value rose 12% quarter-over-quarter to $2.89B.

Based on Piedmont Investment Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.